Segment, Customer and Geographic Information

12 Months Ended

Dec. 31, 2012

Segment, Customer and Geographic Information

Note 18. Segment, Customer and Geographic Information

The Company continues to operate in only one segment, blood safety. The Company’s chief executive officer is the chief operating decision maker who evaluates performance based on the net revenues and operating loss of the blood safety segment. The Company considers the sale of all of its INTERCEPT Blood System products to be similar in nature and function, and any revenue earned from services is minimal.

The Company’s operations outside of the United States include a wholly-owned subsidiary headquartered in Europe. The Company’s operations in the United States are responsible for the research and development and global commercialization of the INTERCEPT Blood System, while operations in Europe are responsible for the commercialization efforts of the platelet and plasma systems in Europe, The Commonwealth of Independent States and the Middle East. Product revenues are attributed to each region based on the location of the customer, and in the case of non-product revenues, on the location of the collaboration partner.

The Company had the following significant customers that accounted for more than 10% of the Company’s total product revenue, all of which operate in a country outside of the United States, during the years ended December 31, 2012, 2011 and 2010 (in percentages):

	Year Ended December 31,
	2012			2011			2010
Etablissement Francais du Sang		20	%		24	%		20	%
Movaco, S.A.		19	%		21	%		19	%
Delrus Inc.		12	%		12	%		16	%
Service Francophone du Sang *		*			*			12	%

* Represents an amount less than 10% of product revenue.

The Company also recognized government grants and cooperative agreements revenue which represented less than 1% of total revenue, 7% of total revenue and 6% of total revenue, during the years ended December 31, 2012, 2011 and 2010, respectively.

Net revenues by geographical location was based on the location of the customer, in the case of product revenues, and in the location of the collaboration partner, in the case of non-product revenues, during the years ended December 31, 2012, 2011 and 2010 and was as follows (in thousands):

	Year Ended December 31,
	2012		2011		2010
Product Revenue:
France	$	7,321	$	7,385	$	4,432
Spain and Portugal		7,061		6,504		4,175
CIS		8,016		3,754		3,383
Belgium		4,016		3,703		3,710
Switzerland		3,866		3,315		1,330
Other countries		6,415		5,941		4,647
Total product revenue		36,695		30,602		21,677
Government grants and cooperative agreements:
United States		91		2,442		1,432
Total government grants and cooperative agreements		91		2,442		1,432
Total revenue	$	36,786	$	33,044	$	23,109

Long-lived assets by geographical location, which consist of property and equipment, net, intangible assets, net, and certain other assets, at December 31, 2012 and 2011 were as follows (in thousands):

	December 31,
	2012		2011
United States	$	2,895	$	3,299
Europe		349		650
Total long-lived assets	$	3,244	$	3,949